Aussie icon Sophie Monk calls on Australians to get behind Melanoma March
26 February 2019
Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
Sophie today toured Melanoma Institute Australia’s research and treatment centre in Sydney, where she met a young family devastated by melanoma. She spent time with little Madi who was only three-years-old when she lost her dad Peter to melanoma.
MIA CEO Matthew Browne says the organisation is thrilled to have Sophie onboard as the Queensland-based media personality is relatable to 15-39 year olds, the age bracket in which melanoma is the most common cancer.
"Sophie, like many Australians, has grown up living an outdoor, active lifestyle which all too often can have dire consequences,” Matthew said. “Many people don’t realise how common melanoma is, with more than 14,000 Australians expected to be diagnosed with the disease this year. By having Sophie onboard we will better be able to reach young Australians with sun-safety and skin awareness messages."
After having a close friend diagnosed with melanoma, and then watching her dad battle with skin cancer, Sophie was shocked to learn that melanoma is the most common cancer affecting 15 to 39 year old Australians.
I love going to the beach as much as the next Australian, but now seeing just how prevalent melanoma is among young people, it has prompted me to spread the sun safety message so no one has to go through this devastating diagnosis, Sophie said.
Sophie will use her public profile as one of Australia’s most loved television and radio personalities to warn other young Aussies of the risk of sun exposure and the need to be vigilant in checking their skin for changes.
"When I first came back to Australia the thing I noticed most was how much time Australians spend in the sun, so I was constantly reminding my family to put on sunscreen. We should all be using sunscreen and checking our skin, in the same way we clean our teeth every day. And if you notice any changes to your skin, you need to get checked professionally ASAP. I know it can be a pain but it could be the difference between life and death. I’ll be nagging all my friends and family to book in to get their initial skin check!"
Sophie has also generously come on board as an Ambassador for Melanoma Institute Australia’s national awareness campaign, Melanoma March, which includes 23 family friendly walks across every state and territory in Australia, as well as the 2000km Jay’s Longest Melanoma March from Adelaide to Sydney. The campaign raises vital funds for melanoma research.
Our goal is zero deaths from melanoma, and whilst recent clinical advances have tripled life expectancy of some advanced melanoma patients, we still have one Australian dying from the disease every five hours,” said Matthew Browne. “It is vital we fund ongoing research so we can save more lives.
"I grew up in sunny Queensland and it’s only through hearing the devastating stories about melanoma that I now realise how deadly the disease can be, and the importance of sun safety, especially among the younger generation,” Sophie said.
Join your local Melanoma March to help raise awareness as well as much-needed funds so that one day no one will have to die from melanoma,” Sophie said.
For more information on how to register for a march near you or donate to Melanoma March, go to www.melanomamarch.org.au
Melanoma March 2019 is an initiative of Melanoma Institute Australia. In South Australia, we work alongside Australian Melanoma Research Foundation; in Western Australia, we work with melanomaWA; and in Victoria, we work with the Skin & Cancer Foundation Inc.
Melanoma March 2019 Principal Partner is Ricky, and Supporting Partners include Sun Sense, Skin & Cancer Foundation Inc., Toyota and Kensington Parry.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.
Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.
CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series.